Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries, a generic pharmaceutical company, has commenced commercial shipment of its generic version of Shire Pharmaceuticals's Adderall XR capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30mg.
Subscribe to our email newsletter
Teva’s generic Adderall XR capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
In August 2006, Teva’s subsidiary Barr Pharmaceuticals entered into a licensing agreement with Shire as part of a settlement of patent litigation between the parties. Under this agreement, Shire granted the company the exclusive right to sell a generic version of Adderall XR capsules for 180 days from the date of commercial launch.